This site is for customers in Asia.
Customers in China & other regions, please go to Global page.
HOME > Product search results
Searched by
Category - cancer
Product（268）
Refine your search
[+]Animal species
[+]Category
[+]Conjugate
[+]MHC Allele
[+]Research area
[+]Tools
[+]Brands
[+]Availability (in Japan)
| Clip | Code No. | Product | Data | |||
|---|---|---|---|---|---|---|
| Data
Sheet |
Category | Conjugate | MHC Allele | Size | Availability | |
| Sequence | Location (aa) | Storage
temp. |
||||
|
|
||||||
|
TB-0014-1 |
iTAg Tetramer/PE – HLA-A*02:01 gp100 (ITDQVPFSV)
|
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| ITDQVPFSV | 209-217 | 4°C | ||||
|
|
TB-5105-4 |
H-2Kd MAGE-A3 Tetramer-SYVKVLHHM-BV421 |
|
|||
| cancer | BV421 | H-2Kd | 50 tests |
0 (Contact us) |
||
| SYVKVLHHM | 4°C | |||||
|
|
TB-0166-1 |
HLA-A*03:01 gp100 Tetramer-ALLAVGATK-PE |
|
|||
| cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
||
| ALLAVGATK | 4°C | |||||
|
|
TB-0120-2 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| YLEPGPVTV | 4°C | |||||
|
|
TB-0112-4 |
HLA-A*02:01 Mesothelin Tetramer-VLPLTVAEV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| VLPLTVAEV | 4°C | |||||
|
|
TB-0105-2 |
HLA-A*03:01 hTERT Tetramer-KLFGVLRLK-APC |
|
|||
| cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
||
| KLFGVLRLK | 4°C | |||||
|
|
TB-0016-4 |
T-Select HLA-A*02:01 Her-2/neu Tetramer-RLLQETELV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| RLLQETELV | 689-697 | 4°C | ||||
|
|
TB-5108-2 |
H-2Db Survivin Tetramer-ATFKNWPFL-APC |
|
|||
| cancer | APC | H-2Db | 50 tests |
0 (Contact us) |
||
| ATFKNWPFL | 20-28 | 4°C | ||||
|
|
TB-0163-1 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| YLGSYGFRL | 103-111 | 4°C | ||||
|
|
TB-0159-4 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| SLPPPGTRV | 149-157 | 4°C | ||||
|
|
TB-0156-2 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| QLCPICRAPV | 175-184 | 4°C | ||||
|
|
TB-0151-4 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| GLQHWVPEL | 97-106 | 4°C | ||||
|
|
TB-0150-4 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| GLLGASVLGL | 674-683 | 4°C | ||||
|
|
TB-0150-1 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| GLLGASVLGL | 674-683 | 4°C | ||||
|
|
TS-M095-2 |
HLA-A*02:01 PP2A Tetramer-SLLPAIVEL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLLPAIVEL | 402-410 | 4°C | ||||
|
|
TB-M120-1 |
HLA-A*02:01 PSA 141-150 Tetramer-FLTPKKLQCV-PE
|
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| FLTPKKLQCV | 141-150 | 4°C | ||||
|
|
TB-0114-4 |
HLA-A*02:01 hTERT Tetramer-YLQVNSLQTV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| YLQVNSLQTV | 4°C | |||||
|
|
TB-0114-1 |
HLA-A*02:01 hTERT Tetramer-YLQVNSLQTV-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| YLQVNSLQTV | 4°C | |||||
|
|
TB-0113-1 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| YLFFYRKSV | 4°C | |||||
|
|
TB-0112-2 |
HLA-A*02:01 Mesothelin Tetramer-VLPLTVAEV-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| VLPLTVAEV | 4°C | |||||
|
|
TB-0017-1 |
T-Select HLA-A*02:01 PR-1 Tetramer-VLQELNVTV-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| VLQELNVTV | 169-177 | 4°C | ||||
|
|
TB-0013-4 |
T-Select HLA-A*02:01 gp100 (mutant) Tetramer-IMDQVPFSV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| IMDQVPFSV | 209-217 | 4°C | ||||
|
|
TB-0155-4 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| LTLGEFLKL | 96-104 | 4°C | ||||
|
|
TB-0153-1 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| LLLTVLTVV | 13-21 | 4°C | ||||
|
|
TB-0159-1 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| SLPPPGTRV | 149-157 | 4°C | ||||
|
|
TB-0158-1 |
HLA-A*02:01 CD20 Tetramer-SLFLGILSV-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| SLFLGILSV | 188-196 | 4°C | ||||
|
|
TB-0156-4 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| QLCPICRAPV | 175-184 | 4°C | ||||
|
|
TB-0156-1 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| QLCPICRAPV | 175-184 | 4°C | ||||
|
|
TB-0152-2 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| KLCPVQLWV | 139-147 | 4°C | ||||
|
|
TB-0139-2 |
HLA-A*24:02 PSA Tetramer-CYASGWGSI-APC |
|
|||
| cancer | APC | A*24:02 | 50 tests |
0 (Contact us) |
||
| CYASGWGSI | 153-161 | 4°C | ||||
|
|
TB-0136-4 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| GLAPPQHLIRV | 187-197 | 4°C | ||||
|
|
TB-0127-4 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| AILALLPAL | 105-133 | 4°C | ||||
|
|
TB-0126-4 |
HLA-A*01:01 Tyrosinase Tetramer-KSDICTDEY-BV421 |
|
|||
| cancer | BV421 | A*01:01 | 50 tests |
0 (Contact us) |
||
| KSDICTDEY | 243-251 | 4°C | ||||
|
|
TS-M071-2 |
HLA-B*07:02 MAGE-A1 Tetramer-RVRFFFPSL-APC |
|
|||
|
|
cancer | APC | B*07:02 | 50 tests | 1-9 | |
| RVRFFFPSL | 289-297 | 4°C | ||||
|
|
TB-M075-2 |
HLA-A*02:01 MAGE-A3 112-120 Tetramer-KVAELVHFL-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| KVAELVHFL | 112-120 | 4°C | ||||
|
|
TB-0017-2 |
T-Select HLA-A*02:01 PR-1 Tetramer-VLQELNVTV-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| VLQELNVTV | 169-177 | 4°C | ||||
|
|
TB-0155-2 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| LTLGEFLKL | 96-104 | 4°C | ||||
|
|
TB-0155-1 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| LTLGEFLKL | 96-104 | 4°C | ||||
|
|
TB-0169-4 |
HLA-A*02:01 BCR-ABL Tetramer-GVRGRVEEI-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| GVRGRVEEI | bcr-abl fusion protein | 4°C | ||||
|
|
TB-0163-4 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| YLGSYGFRL | 103-111 | 4°C | ||||
|
|
TB-0163-2 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| YLGSYGFRL | 103-111 | 4°C | ||||
|
|
TB-0158-4 |
HLA-A*02:01 CD20 Tetramer-SLFLGILSV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| SLFLGILSV | 188-196 | 4°C | ||||
|
|
TB-0152-4 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| KLCPVQLWV | 139-147 | 4°C | ||||
|
|
TB-0134-4 |
HLA-A*02:01 GPC3 Tetramer-FVGEFFTDV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| FVGEFFTDV | 144-152 | 4°C | ||||
|
|
TB-0128-4 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| ALLTSRLRFI | 615-624 | 4°C | ||||
|
|
TB-0119-2 |
HLA-B*07:02 Tyrosinase Tetramer-LPWHRLFLL-APC |
|
|||
| cancer | APC | B*07:02 | 50 tests |
0 (Contact us) |
||
| LPWHRLFLL | 208-216 | 4°C | ||||
|
|
TB-0166-4 |
HLA-A*03:01 gp100 Tetramer-ALLAVGATK-BV421 |
|
|||
| cancer | BV421 | A*03:01 | 50 tests |
0 (Contact us) |
||
| ALLAVGATK | 4°C | |||||
|
|
TB-0112-1 |
HLA-A*02:01 Mesothelin Tetramer-VLPLTVAEV-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| VLPLTVAEV | 4°C | |||||
|
|
TB-0110-2 |
HLA-A*02:01 Mesothelin Tetramer-SLLFLLFSL-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| SLLFLLFSL | 4°C | |||||
|
|
TB-0153-4 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| LLLTVLTVV | 13-21 | 4°C | ||||
|
|
TB-0161-2 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| VLAGGFFLL | 27-38 | 4°C | ||||
|
|
TB-0134-2 |
HLA-A*02:01 GPC3 Tetramer-FVGEFFTDV-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| FVGEFFTDV | 144-152 | 4°C | ||||
|
|
TB-0128-2 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| ALLTSRLRFI | 615-624 | 4°C | ||||
|
|
TB-0119-1 |
HLA-B*07:02 Tyrosinase Tetramer-LPWHRLFLL-PE |
|
|||
| cancer | PE | B*07:02 | 50 tests |
0 (Contact us) |
||
| LPWHRLFLL | 208-216 | 4°C | ||||
|
|
TB-0153-2 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| LLLTVLTVV | 13-21 | 4°C | ||||
|
|
TB-0164-1 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| YMCSFLFNL | 666-674 | 4°C | ||||
|
|
TB-0139-4 |
HLA-A*24:02 PSA Tetramer-CYASGWGSI-BV421 |
|
|||
| cancer | BV421 | A*24:02 | 50 tests |
0 (Contact us) |
||
| CYASGWGSI | 153-161 | 4°C | ||||
|
|
TB-0129-4 |
HLA-B*35:01 NY-ESO-1 Tetramer-MPFATPMEA-BV421 |
|
|||
| cancer | BV421 | B*35:01 | 50 tests |
0 (Contact us) |
||
| MPFATPMEA | 94-102 | 4°C | ||||
|
|
TB-0114-2 |
HLA-A*02:01 hTERT Tetramer-YLQVNSLQTV-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| YLQVNSLQTV | 4°C | |||||
|
|
TB-0169-2 |
HLA-A*02:01 BCR-ABL Tetramer-GVRGRVEEI-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| GVRGRVEEI | bcr-abl fusion protein | 4°C | ||||
|
|
TB-0169-1 |
HLA-A*02:01 BCR-ABL Tetramer-GVRGRVEEI-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| GVRGRVEEI | bcr-abl fusion protein | 4°C | ||||
|
|
TB-0164-4 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| YMCSFLFNL | 666-674 | 4°C | ||||
|
|
TB-0126-2 |
HLA-A*01:01 Tyrosinase Tetramer-KSDICTDEY-APC |
|
|||
| cancer | APC | A*01:01 | 50 tests |
0 (Contact us) |
||
| KSDICTDEY | 243-251 | 4°C | ||||
|
|
TB-0161-1 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| VLAGGFFLL | 27-38 | 4°C | ||||
|
|
TB-0151-1 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| GLQHWVPEL | 97-106 | 4°C | ||||
|
|
TB-0150-2 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| GLLGASVLGL | 674-683 | 4°C | ||||
|
|
TB-0134-1 |
HLA-A*02:01 GPC3 Tetramer-FVGEFFTDV-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| FVGEFFTDV | 144-152 | 4°C | ||||
|
|
TB-0128-1 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| ALLTSRLRFI | 615-624 | 4°C | ||||
- The availability is based on the information in Japan at 17:00, Apr 18, 2024 in JST.
- The special price is shown in red color.
- Please note that products cannot be ordered from this website. To purchase the items listed in this website, please contact us or local distributers.
- For storage temparature: RT: room temparature
- Please note that products in this website might be changed or discontinued without notification in advance for quality improvement.